Short answer: The labels say it can. Each estrogen label we checked says estrogen may worsen asthma, diabetes, epilepsy, migraine, porphyria, lupus and liver hemangiomas, and has separate warnings for very high triglycerides, low thyroid, hypoparathyroidism, endometriosis and hereditary angioedema. A sudden migraine is also listed with vision changes as a reason to stop estrogen until an eye exam.
Migraine appears in three places in the Climara, EstroGel, Premarin and Prempro labels. First, in the section on other conditions (section 5.16 or 5.17), estrogen therapy may cause an exacerbation of migraine. Second, under vision problems (section 5.6), retinal vascular thrombosis, a clot in the eye, has been reported, and estrogen is stopped pending an exam if there is sudden vision loss, bulging of the eye, double vision or a sudden migraine. Third, migraine is listed among reported side effects in section 6.
The labels give no rate for migraine worsening and do not separate migraine with aura from migraine without it.
| Condition | What the label says |
|---|---|
| Asthma, diabetes, epilepsy, migraine, porphyria, lupus, liver hemangiomas | Estrogen may cause an exacerbation; weigh benefits against risks (5.16) |
| Very high triglycerides | In women who already have high triglycerides, estrogen may raise them further, leading to pancreatitis; stop if pancreatitis occurs (5.9) |
| Hypothyroidism on thyroid medicine | Estrogen raises thyroid-binding globulin; a higher thyroid dose may be needed, with thyroid tests during treatment (5.11) |
| Hypoparathyroidism | Estrogen-induced low calcium may occur (5.13) |
| Endometriosis after hysterectomy | A few cases of cancer in leftover endometriosis on estrogen alone; adding a progestogen can be considered (5.14) |
| Hereditary angioedema | Estrogen may worsen swelling episodes (5.15) |
| Heart or kidney conditions | Estrogen may cause fluid retention; monitor (5.12) |
Some of these come with a specific step. For women on thyroid medicine, thyroid tests are checked during treatment so free hormone levels stay in range. For women with high triglycerides, estrogen is stopped if pancreatitis occurs. For hypoparathyroidism and hereditary angioedema, Climara asks whether the benefits of estrogen outweigh the risks. The thyroid point is covered in estrogen and thyroid medicine.
These are written as precautions. The labels ask the prescriber to consider whether the benefits of estrogen outweigh the risks (Climara, EstroGel) or to use it with caution (Premarin, Prempro). The Patient Information leaflets tell women that the healthcare provider may need to check them more carefully if they have asthma, epilepsy, diabetes, migraine, endometriosis, lupus, angioedema, or heart, liver, thyroid or kidney problems.
Someone with migraines who starts or changes hormone therapy can tell the prescriber about the migraine type and pattern before starting. Logging headaches in Dose Track alongside each patch change, gel dose or pill shows whether they cluster around a dose change or a gap. A sudden migraine with vision changes is, in the labels, a reason to stop estrogen until an eye exam.
Read more on Dose Track: Menopause · Climara side effects · EstroGel side effects · Vasomotor symptoms